Unveiling the potential of CLL-1: a promising target for AML therapy

Unveiling the potential of CLL-1: a promising target for AML therapy

Abstract Acute myeloid leukemia (AML) remains a formidable blood cancer, despite recent advances in treatment. A significant challenge persists in improving patient outcomes, particularly in addressing relapse and treatment resistance. Identifying new therapeutic targets is critical for advancing AM...

Full description

Saved in:
Bibliographic Details
Main Authors: Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji, Safedin H. Beqaj, Shamim Tayefeh, Mohammad Hossein Mohammadi, Mojtaba Aghaei
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Biomarker Research
Subjects:
C-type lectin-like molecule-1
Macrophages
Graft-versus-host disease
Immunotherapy
Inflammation
Transplantation
Online Access:https://doi.org/10.1186/s40364-025-00738-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40364-025-00738-6

Similar Items